Researchers report that getting the shingles vaccine is associated with a lower risk of cardiovascular outcomes, including stroke, heart disease, and heart failure. The findings come from an analysis comparing people who received the vaccine with those who did not, and they focus on risk differences related to the vaccine currently in use.
Several outlets describe the results as an improvement over earlier evidence. One report notes that prior studies suggested links between shingles vaccination and cardiovascular benefits, but this work finds larger odds reductions with the vaccine version used now. Another outlet emphasizes the potential breadth of the benefits, highlighting stroke, heart disease, and heart failure.
While the studies draw attention to a possible protective association, the reports reflect that the relationship is observational and does not prove cause and effect. The vaccine is designed to prevent shingles, and the cardiovascular findings are presented as additional risk reductions tied to vaccination rather than as a change in the vaccine’s purpose.
